Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 327 articles:
HTML format



Single Articles


    August 2022
  1. YEP MANZANO IS, Agrawal A
    A Comparative Study of Drain in Oncoplastic Breast Conserving Surgery (Therapeutic Mammaplasty and Chest Wall Perforator Flap Partial Breast Reconstruction) vs. Mastectomy.
    Clin Breast Cancer. 2022;22:619-627.
    PubMed     Abstract available


  2. USLU H, Tosun M
    The benefit of superb microvascular imaging and shear wave elastography in differentiating metastatic axillary lymphadenopathy from lymphadenitis.
    Clin Breast Cancer. 2022;22:515-520.
    PubMed     Abstract available


  3. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
    Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database.
    Clin Breast Cancer. 2022;22:547-552.
    PubMed     Abstract available


  4. SAYAN M, Kilic SS, Vergalasova I, Jan I, et al
    Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.
    Clin Breast Cancer. 2022;22:553-559.
    PubMed     Abstract available


    July 2022
  5. MURCHISON S, Nichol A, Speers C, Gondara L, et al
    Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.
    Clin Breast Cancer. 2022 Jul 12. pii: S1526-8209(22)00145.
    PubMed     Abstract available


  6. LAN B, Lv D, Sun X, Yang M, et al
    Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer.
    Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00144.
    PubMed     Abstract available


  7. VATHIOTIS IA, Trontzas I, Gavrielatou N, Gomatou G, et al
    Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.
    Clin Breast Cancer. 2022 Jul 7. pii: S1526-8209(22)00140.
    PubMed     Abstract available


  8. MORAES MO, Forte GC, Guimaraes ADSG, Grando MBFDP, et al
    Breast MRI: Simplifying Protocol and BI-RADS Categories.
    Clin Breast Cancer. 2022;22:e615-e622.
    PubMed     Abstract available


  9. DE VITA R, Villanucci A, Buccheri EM, Pozzi M, et al
    Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method).
    Clin Breast Cancer. 2022;22:e623-e628.
    PubMed     Abstract available


  10. MICHA A, Parvaiz MA, O'Riordan L, MacNeill F, et al
    Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes.
    Clin Breast Cancer. 2022;22:e636-e640.
    PubMed     Abstract available


  11. XIE Y, Wang Q, Hu T, Chen R, et al
    Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
    Clin Breast Cancer. 2022;22:e685-e690.
    PubMed     Abstract available


  12. OMISORE AD, Odedeyi AA, Famurewa OC, Olasehinde O, et al
    Practice, Perceptions, and Prospects of Mammography Screening in Nigeria: Insights From a National Survey of Female Health Workers.
    Clin Breast Cancer. 2022;22:462-472.
    PubMed     Abstract available


  13. TANVEER N, Dixit S, Jain P, Rani P, et al
    Static smartphone images supplemented by videoconferencing for breast telepathology.
    Clin Breast Cancer. 2022;22:455-461.
    PubMed     Abstract available


  14. MAYROVITZ HN, Weingrad DN
    Tissue Dielectric Constant Differentials between Malignant and Benign Breast Tumors.
    Clin Breast Cancer. 2022;22:473-477.
    PubMed     Abstract available


  15. AROLE V, Shafi S, Challa B, Parwani AV, et al
    Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
    Clin Breast Cancer. 2022;22:e680-e684.
    PubMed     Abstract available


  16. KELLY BN, Webster AJ, Lamb L, Spivey T, et al
    Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions.
    Clin Breast Cancer. 2022;22:e700-e707.
    PubMed     Abstract available


    June 2022
  17. TUN SM, Alluri S, Rastegar V, Visintainer P, et al
    Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2022 Jun 29. pii: S1526-8209(22)00139.
    PubMed     Abstract available


  18. MENG X, Chang X, Wang X, Guo Y, et al
    Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jun 26. pii: S1526-8209(22)00138.
    PubMed     Abstract available


  19. REDEMSKI T, Hamilton DG, Schuler S, Liang R, et al
    Rehabilitation for Women Undergoing Breast Cancer Surgery: A Systematic Review and Meta-Analysis of the Effectiveness of Early, Unrestricted Exercise Programs on Upper Limb Function.
    Clin Breast Cancer. 2022 Jun 24. pii: S1526-8209(22)00137.
    PubMed     Abstract available


  20. LIU H, Mei Y, Ma X, Zhang X, et al
    FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway.
    Clin Breast Cancer. 2022 Jun 2. pii: S1526-8209(22)00115.
    PubMed     Abstract available


  21. SHEIKH SE, Rathbone M, Chaudhary K, Joshi A, et al
    Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit.
    Clin Breast Cancer. 2022;22:381-390.
    PubMed     Abstract available


  22. VRANIC S, Gatalica Z
    An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
    Clin Breast Cancer. 2022;22:e576-e585.
    PubMed     Abstract available


  23. PETROLLA A, Hicks DG, Skinner KA, Wang X, et al
    Detailed Morphologic Evaluation of Breast Papillary Lesions on Core Biopsy Is Critical for Accurate Classification and Clinical Management: The Experience of an Academic Institute.
    Clin Breast Cancer. 2022;22:e552-e557.
    PubMed     Abstract available


  24. GU Y, Tian J, Ran H, Ren W, et al
    Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?
    Clin Breast Cancer. 2022;22:e407-e416.
    PubMed     Abstract available


    May 2022
  25. OKINES AFC, Irfan T, Mohammed K, Ring A, et al
    Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
    Clin Breast Cancer. 2022 May 27. pii: S1526-8209(22)00113.
    PubMed     Abstract available


  26. MICELI R, Cao C, Maolanon NN, Jacobs R, et al
    Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study.
    Clin Breast Cancer. 2022 May 23. pii: S1526-8209(22)00112.
    PubMed     Abstract available


  27. HOUZARD S, Courtois E, Le Bihan Benjamin C, Erbault M, et al
    Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
    Clin Breast Cancer. 2022 May 21. pii: S1526-8209(22)00096.
    PubMed     Abstract available


  28. MALLA R, Puvalachetty K, Vempati RK, Marni R, et al
    Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Clin Breast Cancer. 2022 May 19. pii: S1526-8209(22)00094.
    PubMed     Abstract available


  29. PATT D, Liu X, Li B, McRoy L, et al
    Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00081.
    PubMed     Abstract available


  30. POTERALA JE, Havighurst T, Braun Wisinski K
    Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00080.
    PubMed     Abstract available


    April 2022
  31. HEYLEN J, Punie K, Smeets A, Neven P, et al
    Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00076.
    PubMed     Abstract available


  32. TONG QY, Liu R, Gao Y, Zhang K, et al
    Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00079.
    PubMed     Abstract available


  33. SNIDER K, Moore T, Walters C, Brachtenbach T, et al
    An Analysis of the Evidence Informing Clinical Practice Guidelines in the Management and Treatment of Breast Cancer.
    Clin Breast Cancer. 2022 Apr 29. pii: S1526-8209(22)00078.
    PubMed     Abstract available


  34. ARIFFIN NS
    RUNX1 as a Novel Molecular Target for Breast Cancer.
    Clin Breast Cancer. 2022 Apr 26. pii: S1526-8209(22)00075.
    PubMed     Abstract available


  35. MEHRAJ U, Alshehri B, Khan AA, Bhat AA, et al
    Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.
    Clin Breast Cancer. 2022 Apr 25. pii: S1526-8209(22)00077.
    PubMed     Abstract available


  36. YAMADA D, Ohde S, Kajiura Y, Yagishita K, et al
    Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis.
    Clin Breast Cancer. 2022 Apr 22. pii: S1526-8209(22)00074.
    PubMed     Abstract available


  37. VANGURI RS, Fenn KM, Kearney MR, Wang Q, et al
    Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
    Clin Breast Cancer. 2022 Apr 18. pii: S1526-8209(22)00071.
    PubMed     Abstract available


  38. UDDIN MN, Wang X
    Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma.
    Clin Breast Cancer. 2022 Apr 5. pii: S1526-8209(22)00070.
    PubMed     Abstract available


  39. TWELVES C, Bartsch R, Ben-Baruch NE, Borstnar S, et al
    The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC.
    Clin Breast Cancer. 2022;22:223-234.
    PubMed     Abstract available


  40. SHIN HJ, Choi WJ, Park SY, Ahn SH, et al
    Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Clin Breast Cancer. 2022;22:e374-e386.
    PubMed     Abstract available


  41. ZENG A, Brennan ME, Young S, Mathieu E, et al
    The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review.
    Clin Breast Cancer. 2022;22:212-222.
    PubMed     Abstract available


  42. BRADBURY M, Hutton B, Beltran-Bless AA, Alzahrani M, et al
    Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
    Clin Breast Cancer. 2022;22:e362-e373.
    PubMed     Abstract available


  43. LIN X, He Y, Fu S, Lin S, et al
    The Ultrasonographic Characteristics of Focal Fibrocystic Change of the Breast and Analysis of Misdiagnosis.
    Clin Breast Cancer. 2022;22:252-260.
    PubMed     Abstract available


  44. LOTZ M, Ghebremichael M, Chervinsky K, Zorc T, et al
    Effective Surveillance of High-Risk Women.
    Clin Breast Cancer. 2022;22:e263-e269.
    PubMed     Abstract available


    March 2022
  45. HE Y, Gao X, Wu J, Li X, et al
    Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
    Clin Breast Cancer. 2022 Mar 31. pii: S1526-8209(22)00069.
    PubMed     Abstract available


  46. JACOBS W, Schagen SB, Brouwer SM, Kieffer JM, et al
    The Effects of Being Informed About Chemotherapy-Related Cognitive Symptoms With And Without Self-Affirmation on Perceived Cognitive Symptoms of Breast Cancer Patients: A Randomized Prospective, Longitudinal Study.
    Clin Breast Cancer. 2022 Mar 26. pii: S1526-8209(22)00064.
    PubMed     Abstract available


  47. MARCZYK VR, Rosa DD, Maia AL, Goemann IM, et al
    Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study.
    Clin Breast Cancer. 2022 Mar 23. pii: S1526-8209(22)00066.
    PubMed     Abstract available


  48. JIANG C, Zhang S, Qiao K, Xiu Y, et al
    The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Mar 21. pii: S1526-8209(22)00065.
    PubMed     Abstract available


  49. FENG M, Yang Y, Liao W, Li Q, et al
    Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2022 Mar 17. pii: S1526-8209(22)00063.
    PubMed     Abstract available


  50. ZHENG Y, Jiang X, Wang M, Yang S, et al
    BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study.
    Clin Breast Cancer. 2022 Mar 14. pii: S1526-8209(22)00045.
    PubMed     Abstract available


    February 2022
  51. ROSSO C, Voutsadakis IA
    Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression.
    Clin Breast Cancer. 2022 Feb 26. pii: S1526-8209(22)00042.
    PubMed     Abstract available


  52. LIN Y, Yang Y, Zhang X, Li W, et al
    Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2022 Feb 24. pii: S1526-8209(22)00034.
    PubMed     Abstract available


  53. LI L, Xiong Y, Wang N, Zhu M, et al
    Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
    Clin Breast Cancer. 2022 Feb 11. pii: S1526-8209(22)00040.
    PubMed     Abstract available


  54. CANINO F, Omarini C, Cerma K, Moscetti L, et al
    Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
    Clin Breast Cancer. 2022 Feb 7. pii: S1526-8209(22)00036.
    PubMed     Abstract available


  55. SONG Z, Li C, Zhou D, Liu J, et al
    Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00035.
    PubMed     Abstract available


  56. LIBESMAN S, Zackrisson S, Hofvind S, Seidler AL, et al
    An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00037.
    PubMed     Abstract available


  57. MACNAB MF, Slater G, Fuller M, Elsberger B, et al
    The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral Breast Cancer Surgery.
    Clin Breast Cancer. 2022 Feb 3. pii: S1526-8209(22)00033.
    PubMed     Abstract available


  58. FISER CK, Kronenfeld JP, Liu SN, Goel N, et al
    Comparison of Immediate Breast Reconstruction Outcomes in Patients With and Without Prior Cosmetic Breast Surgery.
    Clin Breast Cancer. 2022;22:136-142.
    PubMed     Abstract available


  59. CHOE AI, Ismail R, Mack J, Walter V, et al
    Review of Variables Associated With Positive Surgical Margins Using Scout Reflector Localizations for Breast Conservation Therapy.
    Clin Breast Cancer. 2022;22:e232-e238.
    PubMed     Abstract available


  60. YI M, Peng C, Xia B, Gan L, et al
    CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e191-e198.
    PubMed     Abstract available


  61. GUIRGUIS MS, Checka C, Adrada BE, Whitman GJ, et al
    Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery.
    Clin Breast Cancer. 2022;22:e158-e166.
    PubMed     Abstract available


    January 2022
  62. HAQUE W, Verma V, Schwartz MR, Lim B, et al
    Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00021.
    PubMed     Abstract available


  63. EL-BASSIOUNY NA, Helmy MW, Hassan MAE, Khedr GA, et al
    The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00024.
    PubMed     Abstract available


  64. BILANI N, Ladki S, Yaghi M, Main O, et al
    Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00023.
    PubMed     Abstract available


  65. LIU J, Yu H, Cui H, Wei F, et al
    lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00026.
    PubMed     Abstract available


  66. GHANBARI M, Shahinfar H, Imani H, Safabakhsh M, et al
    Association of Empirically Derived Food-Based Inflammatory Potential of the Diet and Breast Cancer: A Hospital-Based Case-Control Study.
    Clin Breast Cancer. 2022 Jan 21. pii: S1526-8209(21)00371.
    PubMed     Abstract available


  67. ISHII T, Nakano E, Watanabe T, Higashi T, et al
    Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast Cancer.
    Clin Breast Cancer. 2022 Jan 19. pii: S1526-8209(22)00020.
    PubMed     Abstract available


  68. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer.
    Clin Breast Cancer. 2022 Jan 16. pii: S1526-8209(22)00019.
    PubMed     Abstract available


  69. GALINDO CM, Oliveira Ganzella FA, Klassen G, Souza Ramos EA, et al
    Nuances of PFKFB3 Signaling in Breast Cancer.
    Clin Breast Cancer. 2022 Jan 15. pii: S1526-8209(22)00017.
    PubMed     Abstract available


  70. MERFELD EC, Burr AR, Brickson C, Neuman HB, et al
    De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?
    Clin Breast Cancer. 2022 Jan 12. pii: S1526-8209(22)00016.
    PubMed     Abstract available


  71. HADALIN V, Pislar N, Borstnar S, Matos E, et al
    Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Jan 5. pii: S1526-8209(21)00374.
    PubMed     Abstract available


  72. OBISPO B, Rogado J, Lara Alvarez MA
    The Other Cost of the Pandemic.
    Clin Breast Cancer. 2022;22:e108.
    PubMed    


  73. BERNINI M, Sordi S, Bembi N, Meattini I, et al
    Selective Denervation of Pectoralis Major Muscle Improves Cosmetic Outcome and Quality of Life in Retro-Pectoral Implant Based Breast Reconstruction.
    Clin Breast Cancer. 2022;22:60-66.
    PubMed     Abstract available


  74. KANG MM, Hasan Y, Waller J, Saulsberry L, et al
    Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Clin Breast Cancer. 2022;22:e8-e20.
    PubMed     Abstract available


  75. WANG C, Tsang JY, Poon IK, Shao Y, et al
    An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline.
    Clin Breast Cancer. 2022;22:e114-e122.
    PubMed     Abstract available


  76. VARGHESE J, Gohari S, Regrag F, Rizki H, et al
    Breast Density Notification: Current UK National Practice.
    Clin Breast Cancer. 2022;22:e101-e107.
    PubMed     Abstract available


  77. KOH J, Yoon Y, Kim S, Han K, et al
    Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography.
    Clin Breast Cancer. 2022;22:26-31.
    PubMed     Abstract available


  78. AZHAR S, Wyatt LC, Jokhakar V, Patel S, et al
    Associations between Spiritual Health Locus of Control, Perceived Discrimination and Breast and Cervical Cancer Screening for Muslim American Women in New York City.
    Clin Breast Cancer. 2022 Jan 1. pii: S1526-8209(21)00373.
    PubMed     Abstract available


    December 2021
  79. WALSH EM, Mangini N, Fetting J, Armstrong D, et al
    Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
    Clin Breast Cancer. 2021 Dec 30. pii: S1526-8209(21)00358.
    PubMed     Abstract available


  80. RAMOS-MARTINEZ JC, Altamirano-Gomez G, Ramos-Martinez I, Valencia J, et al
    Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Dec 29. pii: S1526-8209(21)00372.
    PubMed     Abstract available


  81. JERUSALEM G, Delea TE, Martin M, De Laurentiis M, et al
    Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/-HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
    Clin Breast Cancer. 2021 Dec 20. pii: S1526-8209(21)00369.
    PubMed     Abstract available


  82. KATHURIA-PRAKASH N, Antrim L, Hornstein N, Sun AW, et al
    Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.
    Clin Breast Cancer. 2021 Dec 17. pii: S1526-8209(21)00356.
    PubMed     Abstract available


  83. DE GROEF A, Demeyer H, de Kinkelder C, Dukers-van Althuis S, et al
    Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study.
    Clin Breast Cancer. 2021 Dec 16. pii: S1526-8209(21)00357.
    PubMed     Abstract available


  84. SHAFAEE MN, Makawita S, Lim B, Ellis MJ, et al
    Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021 Dec 14. pii: S1526-8209(21)00352.
    PubMed     Abstract available


  85. BIHAN-BENJAMIN CL, Bertrand C, Molinie F, Rogel A, et al
    Care pathway of women with interval breast cancer in 2016, based on medico-administrative data.
    Clin Breast Cancer. 2021 Dec 11. pii: S1526-8209(21)00353.
    PubMed     Abstract available


  86. WANG YS, Guo R, Yang DC, Xu Y, et al
    The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population.
    Clin Breast Cancer. 2021 Dec 10. pii: S1526-8209(21)00354.
    PubMed     Abstract available


  87. ZOU H, Liu SH, Yang R, Wu XJ, et al
    Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Clin Breast Cancer. 2021 Dec 3. pii: S1526-8209(21)00347.
    PubMed     Abstract available


  88. ANGARITA FA, Jedrzejko N, Eisen D, Muraca M, et al
    Primary Care Physicians' Perspectives in Leading Breast Cancer Follow-Up Care.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00350.
    PubMed     Abstract available


  89. CAPARICA R, Ma Y, De Angelis C, Richard F, et al
    Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00351.
    PubMed     Abstract available


  90. MACHUCA MPG, Wu WC, Yu BL, Cheng CT, et al
    Determinants of Breast-Conserving Therapy in Early-Stage Breast Cancer Patients: A Nationwide Study.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00344.
    PubMed     Abstract available


  91. MAHTANI R, Oestreicher N, Lalla D, Ogbonnaya A, et al
    Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00349.
    PubMed     Abstract available


  92. VIUFF JH, Greiber IK, Karlsen MA, Storgaard L, et al
    Survival in Women Diagnosed With Breast Cancer During Pregnancy.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00346.
    PubMed     Abstract available


  93. LIN J, Hu H, Shriver CD, Zhu K, et al
    Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00348.
    PubMed     Abstract available


  94. FODOR A, Brombin C, Mangili P, Tummineri R, et al
    Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00345.
    PubMed     Abstract available


  95. HARRIS EER
    Breast Radiation and the Heart: Cardiac Toxicity and Cardiac Avoidance.
    Clin Breast Cancer. 2021;21:492-496.
    PubMed     Abstract available


  96. GUO H, Idrovo JP, Cao J, Roychoudhury S, et al
    Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma.
    Clin Breast Cancer. 2021;21:e638-e646.
    PubMed     Abstract available


  97. LISA A, Losurdo A, Testori A, Tinterri C, et al
    Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction".
    Clin Breast Cancer. 2021;21:e693.
    PubMed    


  98. XU F, Li C, Li X, Huang Q, et al
    Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e704-e714.
    PubMed     Abstract available


  99. VAN DE VOORT EMF, Struik GM, Birnie E, Moelker A, et al
    Thermal Ablation as an Alternative for Surgical Resection of Small (
    Clin Breast Cancer. 2021;21:e715-e730.
    PubMed     Abstract available


    November 2021
  100. CHIRADONI THUNGAPPA S, Maksud T, Raut N, Nagarkar R, et al
    Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicent
    Clin Breast Cancer. 2021 Nov 27. pii: S1526-8209(21)00343.
    PubMed     Abstract available


  101. MULLANGI S, Vasan N
    Genomic Characterization of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Nov 26. pii: S1526-8209(21)00342.
    PubMed     Abstract available


  102. AKINYEMIJU T, Oyekunle T, Salako O, Gupta A, et al
    Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
    Clin Breast Cancer. 2021 Nov 23. pii: S1526-8209(21)00320.
    PubMed     Abstract available


  103. WOOSTER M, McGuinness JE, Fenn KM, Singh VM, et al
    Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide Assay.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00318.
    PubMed     Abstract available


  104. LI GQ, Yao J, Zhou P, Chen DX, et al
    Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00319.
    PubMed     Abstract available


  105. SHAHI S, Meza J, Tandra P, LeVan T, et al
    Gender Differences in Recommended Treatment Decisions among Breast Cancer Patients: A Study Using the National Cancer Database.
    Clin Breast Cancer. 2021 Nov 8. pii: S1526-8209(21)00307.
    PubMed     Abstract available


  106. SILVA DTC, Vanderlei LCM, Palma MR, Ribeiro FE, et al
    Association Between Different Domains of Physical Activity and Body Adiposity Indicators in Breast Cancer Survivors.
    Clin Breast Cancer. 2021 Nov 5. pii: S1526-8209(21)00306.
    PubMed     Abstract available


  107. KANESHIRO K, Kubo M, Taniguchi M, Yamada M, et al
    Current Status and Problems of Breast Cancer Treatment with Schizophrenia.
    Clin Breast Cancer. 2021 Nov 4. pii: S1526-8209(21)00297.
    PubMed     Abstract available


  108. XUE M, Che S, Tian Y, Xie L, et al
    Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2021 Nov 1. pii: S1526-8209(21)00305.
    PubMed     Abstract available


    October 2021
  109. LI W, Hu S, Han Z, Jiang X, et al
    YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
    Clin Breast Cancer. 2021 Oct 29. pii: S1526-8209(21)00298.
    PubMed     Abstract available


  110. YARDLEY DA, Young RR, Adelson KB, Silber AL, et al
    A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00302.
    PubMed     Abstract available


  111. BOLUKBASI Y, Oymak E, Sezen D, Onal C, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00303.
    PubMed    


  112. MEANS-POWELL JA, Mayer IA, Ismail-Khan R, Del Valle L, et al
    A Phase Ib Dose Escalation Trial of RO4929097 (a gamma-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00304.
    PubMed     Abstract available


  113. MILTON L, Behroozian T, Li N, Zhang L, et al
    Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
    Clin Breast Cancer. 2021 Oct 13. pii: S1526-8209(21)00296.
    PubMed     Abstract available


  114. MO H, Renna CE, Moore HCF, Abraham J, et al
    Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
    Clin Breast Cancer. 2021 Oct 9. pii: S1526-8209(21)00293.
    PubMed     Abstract available


  115. CONTE B, Soldato D, Razeti MG, Fregatti P, et al
    De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
    Clin Breast Cancer. 2021 Oct 8. pii: S1526-8209(21)00292.
    PubMed     Abstract available


  116. BENOIT L, Cambra C, Rouzier R, Cottu P, et al
    Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer.
    Clin Breast Cancer. 2021 Oct 1. pii: S1526-8209(21)00291.
    PubMed     Abstract available


  117. DUDLEY CM, Wiener AA, Stankowski-Drengler TJ, Schumacher JR, et al
    Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01).
    Clin Breast Cancer. 2021;21:433-439.
    PubMed     Abstract available


  118. HSIEH K, Housri N, Haffty B, Smith B, et al
    Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy.
    Clin Breast Cancer. 2021;21:408-416.
    PubMed     Abstract available


  119. DAVIS J JR, Boughey JC, Hoskin TL, Day CN, et al
    Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Clin Breast Cancer. 2021;21:458-465.
    PubMed     Abstract available


  120. VARTHOLOMATOS G, Harissis H, Andreou M, Tatsi V, et al
    Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry.
    Clin Breast Cancer. 2021;21:e602-e610.
    PubMed     Abstract available


  121. CARTAGENA LC, McGuire K, Zot P, Pillappa R, et al
    Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
    Clin Breast Cancer. 2021;21:e594-e601.
    PubMed     Abstract available


  122. WU JM, Turashvili G
    A Survey of Breast Pathologists' Practice in Staging Multiple Foci of Invasive Carcinoma.
    Clin Breast Cancer. 2021;21:e506-e511.
    PubMed     Abstract available


    September 2021
  123. GULER OC, Onal C
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00288.
    PubMed    


  124. JIA H, Zheng Y, Wang P, Wei Z, et al
    A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00289.
    PubMed     Abstract available


  125. DE MATTEIS S, Facondo G, Valeriani M, Vullo G, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    Clin Breast Cancer. 2021 Sep 25. pii: S1526-8209(21)00266.
    PubMed     Abstract available


  126. SEALE KN, Tkaczuk KHR
    Circulating Biomarkers in Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00264.
    PubMed     Abstract available


  127. JUNG L, Miske A, Indorf A, Nelson K, et al
    A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00265.
    PubMed     Abstract available


  128. BARLUND M, Takala L, Tianen L, Kellokumpu-Lehtinen PL, et al
    Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources.
    Clin Breast Cancer. 2021 Sep 20. pii: S1526-8209(21)00263.
    PubMed     Abstract available


  129. SAKACH E, O'Regan R, Meisel J, Li X, et al
    Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00261.
    PubMed     Abstract available


  130. LEVASSEUR N, Sun J, Fenton D, Baxter S, et al
    Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00262.
    PubMed     Abstract available


  131. LI Y, Lin Q, Lu X, Li W, et al
    Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00259.
    PubMed     Abstract available


  132. RAO MALLA R, Marni R, Kumari S, Chakraborty A, et al
    Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00260.
    PubMed     Abstract available


    August 2021
  133. LI J, Li Y, Cheng H
    Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00247.
    PubMed     Abstract available


  134. RIBATTI D, Annese T, Tamma R
    Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00246.
    PubMed     Abstract available


  135. ZHU J, Zheng H, Ge C, Lin H, et al
    Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00245.
    PubMed     Abstract available


  136. SINCLAIR WD, Cui X
    The Effects of HER2 on CDK4/6 Activity in Breast Cancer.
    Clin Breast Cancer. 2021 Aug 26. pii: S1526-8209(21)00244.
    PubMed     Abstract available


  137. ALMALKI HS, Lim A, Allen JC, Teo SY, et al
    Usefulness of supplementary ultrasound surveillance in the detection of a second breast cancer in patients with ductal carcinoma in situ.
    Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00243.
    PubMed     Abstract available


  138. LORUSSO P, Hamilton E, Ma C, Vidula N, et al
    A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00240.
    PubMed     Abstract available


  139. BORMAN P, Yaman A, Yasrebi S, Pinar Inanli A, et al
    Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema.
    Clin Breast Cancer. 2021 Aug 19. pii: S1526-8209(21)00242.
    PubMed     Abstract available


  140. KJOE PRLM, van der Wall E, Schagen SB
    Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?
    Clin Breast Cancer. 2021 Aug 14. pii: S1526-8209(21)00239.
    PubMed     Abstract available


  141. GIANNI P, Matenoglou E, Geropoulos G, Agrawal N, et al
    The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.
    Clin Breast Cancer. 2021 Aug 10. pii: S1526-8209(21)00238.
    PubMed     Abstract available


  142. ZHANG S, Cui T, Duan Y, Zhang H, et al
    Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
    Clin Breast Cancer. 2021 Aug 4. pii: S1526-8209(21)00203.
    PubMed     Abstract available


  143. LI Q, Wang K, Yang L, Wu Q, et al
    Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Clin Breast Cancer. 2021;21:360-372.
    PubMed     Abstract available


  144. HADADI I, Rae W, Clarke J, McEntee M, et al
    Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021;21:278-291.
    PubMed     Abstract available


  145. SHAMOUN F, Asaad M, Hanson SE
    Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction.
    Clin Breast Cancer. 2021;21:271-277.
    PubMed     Abstract available


  146. SALGARELLO M, Pagliara D, Barone Adesi L, Visconti G, et al
    Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction.
    Clin Breast Cancer. 2021;21:e454-e461.
    PubMed     Abstract available


  147. AFSHARFARD A, Ebrahimibagha H, Zeinalpour A
    A Novel Local Transposition Flap for Lateral Breast Reconstruction After Breast Conserving Surgery.
    Clin Breast Cancer. 2021;21:e448-e453.
    PubMed     Abstract available


  148. YAMASHITA Y, Tsunoda H, Nagura N, Kajiura Y, et al
    Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
    Clin Breast Cancer. 2021;21:352-359.
    PubMed     Abstract available


  149. MENG X, Ma H, Yin H, Yin H, et al
    Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e368-e376.
    PubMed     Abstract available


  150. GOYAL U, Saboda K, Roe D, Gonzalez VJ, et al
    Prone Positioning With Deep Inspiration Breath Hold for Left Breast Radiotherapy.
    Clin Breast Cancer. 2021;21:e295-e301.
    PubMed     Abstract available


  151. CAPUTO GG, Zingaretti N, Kiprianidis I, Zanfisi C, et al
    Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction.
    Clin Breast Cancer. 2021;21:344-351.
    PubMed     Abstract available


    July 2021
  152. LIU JK, Kaji AH, Roth KG, Hari DM, et al
    Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00172.
    PubMed     Abstract available


  153. TOORANG F, Sasanfar B, Esmaillzadeh A, Zendehdel K, et al
    Adherence to the DASH Diet and Risk of Breast Cancer.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00198.
    PubMed     Abstract available


  154. NORMAN H, Lee KT, Stearns V, Alcorn SR, et al
    Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature.
    Clin Breast Cancer. 2021 Jul 27. pii: S1526-8209(21)00202.
    PubMed     Abstract available


  155. DE WILD SR, Simons JM, Vrancken Peeters MTFD, Smidt ML, et al
    MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX).
    Clin Breast Cancer. 2021 Jul 26. pii: S1526-8209(21)00199.
    PubMed     Abstract available


  156. DE MORAES CL, Cruz E Melo N, Valoyes MAV, Naves do Amaral W, et al
    AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
    Clin Breast Cancer. 2021 Jul 26. pii: S1526-8209(21)00196.
    PubMed     Abstract available


  157. MOTOKI AH, Buttros DAB, Gaspar AL, Almeida-Filho BS, et al
    Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Clin Breast Cancer. 2021 Jul 25. pii: S1526-8209(21)00197.
    PubMed     Abstract available


  158. HAMMOND JB, Scott DW, Kosiorek HE, Parnall TH, et al
    Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population.
    Clin Breast Cancer. 2021 Jul 25. pii: S1526-8209(21)00194.
    PubMed     Abstract available


  159. CASTALDI M, James T
    Breast Cancer and the Male-Female Divide: It's Even More Complicated.
    Clin Breast Cancer. 2021 Jul 21. pii: S1526-8209(21)00139.
    PubMed    


  160. YE F, Wen J, Yang A, Wang Y, et al
    The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis.
    Clin Breast Cancer. 2021 Jul 21. pii: S1526-8209(21)00174.
    PubMed     Abstract available


  161. WEINFURTNER RJ, Raghunand N, Stringfield O, Abdalah M, et al
    MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity.
    Clin Breast Cancer. 2021 Jul 20. pii: S1526-8209(21)00177.
    PubMed     Abstract available


  162. YOO GS, Kang D, Kim IR, Park H, et al
    Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jul 19. pii: S1526-8209(21)00175.
    PubMed     Abstract available


  163. YADAV SK, Silwal S, Yadav S, Krishnamoorthy G, et al
    A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021 Jul 18. pii: S1526-8209(21)00178.
    PubMed     Abstract available


  164. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
    Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database.
    Clin Breast Cancer. 2021 Jul 16. pii: S1526-8209(21)00193.
    PubMed     Abstract available


  165. SIDDIQUI MF, Maalouf NM
    Impact of Incorporating Trabecular Bone Score Into Fracture Risk Assessment and Recommendation for Use of Bone-Modifying Agents in Women With Breast Cancer.
    Clin Breast Cancer. 2021 Jul 15. pii: S1526-8209(21)00181.
    PubMed    


  166. REN T, Lin S, Huang P, Duong TQ, et al
    Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jul 13. pii: S1526-8209(21)00179.
    PubMed     Abstract available


  167. THOMIS S, Devoogdt N, De Vrieze T, Bechter-Hugl B, et al
    Relation Between Early Disturbance of lymphatic transport Visualized With Lymphofluoroscopy and Other Clinical Assessment Methods in Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Jul 10. pii: S1526-8209(21)00176.
    PubMed     Abstract available


  168. HAJI F, Hurvitz SA
    Can Women With HER2-Positive Metastatic Breast Cancer Be Cured?
    Clin Breast Cancer. 2021 Jul 3. pii: S1526-8209(21)00173.
    PubMed     Abstract available


    June 2021
  169. JIANG Y, Xie Q, Chen R
    Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Clin Breast Cancer. 2021 Jun 26. pii: S1526-8209(21)00171.
    PubMed     Abstract available


  170. LIU X, Liu M, Ma H, Wang J, et al
    miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00169.
    PubMed     Abstract available


  171. LU JF, Hu ZQ, Yang MX, Liu WY, et al
    Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00147.
    PubMed     Abstract available


  172. SEKI H, Higeta K, Sakurai T, Sakurada A, et al
    Feasibility Study of Nanoparticle Albumin-Bound-Paclitaxel and S-1 Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00152.
    PubMed     Abstract available


  173. SHENOUDA M, Copley R, Pacioles T, Lebowicz Y, et al
    Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00151.
    PubMed     Abstract available


  174. CHEN M, Wu J, Liu D, Chen W, et al
    Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
    Clin Breast Cancer. 2021 Jun 16. pii: S1526-8209(21)00140.
    PubMed     Abstract available


  175. TOKUI R, Ishitobi M, Kurita T, Hatano T, et al
    A Comparison of the Oncological Outcomes After Breast-Conserving Surgery With or Without Latissimus Dorsi Myocutaneous Flap Reconstruction for Breast Cancer.
    Clin Breast Cancer. 2021 Jun 15. pii: S1526-8209(21)00150.
    PubMed     Abstract available


  176. DONG L, Lin S, Zhong L, Nian D, et al
    Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00146.
    PubMed     Abstract available


  177. SCHLAFSTEIN A, Liu Y, Goyal S, Kahn S, et al
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00148.
    PubMed     Abstract available


  178. OCCHIOGROSSO RH, Ren S, Tayob N, Li T, et al
    Feasibility of an Online Patient Community to Support Older Women With Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00149.
    PubMed     Abstract available


  179. FALCONE V, Reiser E, Grula L, Bago-Horvath Z, et al
    Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2(+) Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00145.
    PubMed     Abstract available


  180. MO H, Jazieh KA, Brinzevich D, Abraham J, et al
    A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00142.
    PubMed     Abstract available


  181. CERNUSCO NLV, Bianco PD, Romano M, Muraglia A, et al
    Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00143.
    PubMed     Abstract available


  182. BORTOLOZO HI, Derchain S, Vechin FC, Maginador GF, et al
    Aerobic Fitness is a Predictor of Body Composition in Women With Breast Cancer at Diagnosis.
    Clin Breast Cancer. 2021;21:e245-e251.
    PubMed     Abstract available


  183. ANAND K, Niravath P, Patel T, Ensor J, et al
    A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
    Clin Breast Cancer. 2021;21:199-204.
    PubMed     Abstract available


  184. FORTUNATO L, Loreti A, Cortese G, Spallone D, et al
    Regret and Quality of Life After Mastectomy With or Without Reconstruction.
    Clin Breast Cancer. 2021;21:162-169.
    PubMed     Abstract available


  185. ABOUELAZAYEM M, Elkorety M, Monib S
    Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review.
    Clin Breast Cancer. 2021;21:156-161.
    PubMed     Abstract available


  186. BRUNO E, Oliverio A, Paradiso A, Daniele A, et al
    Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort.
    Clin Breast Cancer. 2021;21:e168-e176.
    PubMed     Abstract available


  187. JAFFERBHOY SF, Goussous G, Chandarana M, Salehi-Bird S, et al
    Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy.
    Clin Breast Cancer. 2021;21:e194-e198.
    PubMed     Abstract available


  188. LONG R, Cao K, Cao M, Li XT, et al
    Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
    Clin Breast Cancer. 2021;21:256-262.
    PubMed     Abstract available


  189. KIM H, Vargo JA, Smith KJ, Beriwal S, et al
    Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment.
    Clin Breast Cancer. 2021;21:e271-e278.
    PubMed     Abstract available


  190. DE OLIVEIRA-JUNIOR I, Brandini da Silva FC, Nazima F, Ribeiro JC Jr, et al
    Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?
    Clin Breast Cancer. 2021;21:247-255.
    PubMed     Abstract available


  191. NAIR NS, Chitkara G, Hawaldar RW, Parmar V, et al
    En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome.
    Clin Breast Cancer. 2021;21:e228-e234.
    PubMed     Abstract available


  192. COBB AN, Janjua HM, Kuo PC
    Big Data Solutions for Controversies in Breast Cancer Treatment.
    Clin Breast Cancer. 2021;21:e199-e203.
    PubMed     Abstract available


  193. ANDRIKOPOULOU A, Zografos E, Liontos M, Koutsoukos K, et al
    Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.
    Clin Breast Cancer. 2021;21:e212-e219.
    PubMed     Abstract available


  194. BILANI N, Elson L, Liang H, Elimimian EB, et al
    Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2021;21:170-180.
    PubMed     Abstract available


  195. SUN J, Henry DA, Carr MJ, Yazdankhahkenary A, et al
    Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
    Clin Breast Cancer. 2021;21:e189-e193.
    PubMed     Abstract available


    May 2021
  196. HATZIPANAGIOTOU ME, Huber D, Gerthofer V, Hetterich M, et al
    Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment.
    Clin Breast Cancer. 2021 May 26. pii: S1526-8209(21)00138.
    PubMed     Abstract available


  197. SYMONDS L, Jenkins I, Linden HM, Kurland B, et al
    A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Ca
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00137.
    PubMed     Abstract available


  198. MEYER C, Bailleux C, Chamorey E, Schiappa R, et al
    Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00135.
    PubMed     Abstract available


  199. HE X, Dai X, Ji J, Liu H, et al
    Nine-Year Median Follow-up of Ccardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00136.
    PubMed     Abstract available


  200. DENG C, Xie Y, Liu Y, Li Y, et al
    Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial.
    Clin Breast Cancer. 2021 May 20. pii: S1526-8209(21)00134.
    PubMed     Abstract available


  201. WANG M, Liu H, Wu W, Zhao J, et al
    Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
    Clin Breast Cancer. 2021 May 18. pii: S1526-8209(21)00131.
    PubMed     Abstract available


  202. MEMON R, Prieto Granada CN, Harada S, Winokur T, et al
    Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study: Discordance between HER2 overex
    Clin Breast Cancer. 2021 May 17. pii: S1526-8209(21)00132.
    PubMed     Abstract available


  203. GUILLERM SO, Bourstyn E, Itti R, Cahen-Doidy L, et al
    Intraoperative Radiotherapy for Breast Cancer in Elderly Women.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00130.
    PubMed     Abstract available


  204. HAMILTON EP, Kaklamani V, Falkson C, Vidal GA, et al
    Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00089.
    PubMed     Abstract available


  205. ZHOU J, Liu Y, Xu M, Mei L, et al
    Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00114.
    PubMed     Abstract available


  206. JI X, Li D, Gao D, Lv X, et al
    Value of Ultrasound-Guided Biopsy in Evaluating Internal Mammary Lymph Node Metastases in Breast Cancer.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00116.
    PubMed     Abstract available


  207. TJOE JA, Heslin K, Perez Moreno AC, Thomas S, et al
    Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?
    Clin Breast Cancer. 2021 May 3. pii: S1526-8209(21)00090.
    PubMed     Abstract available


    April 2021
  208. JIA L, Ling Y, Li K, Zhang L, et al
    A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Apr 29. pii: S1526-8209(21)00088.
    PubMed     Abstract available


  209. SHAPIRO CL
    Bone-modifying Agents (BMAs) in Breast Cancer.
    Clin Breast Cancer. 2021 Apr 26. pii: S1526-8209(21)00087.
    PubMed     Abstract available


  210. SHEIKHHOSSEIN F, Shab-Bidar S, Amini MR, Hosseini F, et al
    Dietary Insulin Index and Insulin Load in Relation to Breast Cancer: Findings from a Case-Control Study.
    Clin Breast Cancer. 2021 Apr 24. pii: S1526-8209(21)00086.
    PubMed     Abstract available


  211. LEE Y, Kang E, Shin HC, Lee H, et al
    The Effect of Body Mass Index on Initial Breast Cancer Stage Among Korean Women.
    Clin Breast Cancer. 2021 Apr 22. pii: S1526-8209(21)00085.
    PubMed     Abstract available


  212. WERUTSKY G, Reinert T, Rosa ML, Barrios CH, et al
    Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00071.
    PubMed     Abstract available


  213. VILLARREAL-GARZA C, Ferrigno AS, Mesa-Chavez F, Platas A, et al
    Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00083.
    PubMed     Abstract available


  214. PANG J, Zhou H, Dong X, Wang S, et al
    Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2021 Apr 14. pii: S1526-8209(21)00072.
    PubMed     Abstract available


  215. ECE SOLMAZ A, Yeniay L, Gokmen E, Zekioglu O, et al
    Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 12. pii: S1526-8209(21)00070.
    PubMed     Abstract available


  216. LI X, Yan C, Xiao J, Xu X, et al
    Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Clin Breast Cancer. 2021 Apr 8. pii: S1526-8209(21)00066.
    PubMed     Abstract available


  217. ARIF KMT, Bradshaw G, Nguyen TTN, Smith RA, et al
    Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of Breast Cancer in Australian Caucasian Women.
    Clin Breast Cancer. 2021 Apr 5. pii: S1526-8209(21)00067.
    PubMed     Abstract available


  218. SILVA FR, Grande AJ, Lacerda Macedo AC, Colonetti T, et al
    Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users.
    Clin Breast Cancer. 2021 Apr 3. pii: S1526-8209(21)00068.
    PubMed     Abstract available


  219. WITT JS, Wisinski KB, Anderson BM
    Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier.
    Clin Breast Cancer. 2021;21:120-127.
    PubMed     Abstract available


  220. CASEY DL, Gupta GP, Ollila DW
    The Role of Intraoperative Radiation in Early-stage Breast Cancer.
    Clin Breast Cancer. 2021;21:103-111.
    PubMed     Abstract available


  221. WISINSKI K, O'Regan R
    Introduction to Special Issue.
    Clin Breast Cancer. 2021;21:95.
    PubMed    


  222. MONTAGNA G, Morrow M
    Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer.
    Clin Breast Cancer. 2021;21:112-119.
    PubMed     Abstract available


  223. HEPEL JT, Wazer DE
    Update on Partial Breast Irradiation.
    Clin Breast Cancer. 2021;21:96-102.
    PubMed     Abstract available


    March 2021
  224. REINERT T, de Souza ABA, Rosa ML, Bedin SR, et al
    Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Mar 27. pii: S1526-8209(21)00065.
    PubMed     Abstract available


  225. MCEVOY MP, Ravetch E, Patel G, Fox J, et al
    Prevention of Breast Cancer-Related Lymphedema.
    Clin Breast Cancer. 2021 Mar 17. pii: S1526-8209(21)00051.
    PubMed     Abstract available


  226. NGUYEN AT, Shiao SL, McArthur HL
    Advances in Combining Radiation and Immunotherapy in Breast Cancer.
    Clin Breast Cancer. 2021 Mar 16. pii: S1526-8209(21)00062.
    PubMed     Abstract available


  227. HALEY B, Batra K, Sahoo S, Froehlich T, et al
    A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
    Clin Breast Cancer. 2021 Mar 11. pii: S1526-8209(21)00060.
    PubMed     Abstract available


  228. JOY AA, Vos LJ, Pituskin E, Cook SF, et al
    Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.
    Clin Breast Cancer. 2021 Mar 6. pii: S1526-8209(21)00056.
    PubMed     Abstract available


  229. LEE E, Tweed C, Mylander C, Martino L, et al
    The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
    Clin Breast Cancer. 2021 Mar 4. pii: S1526-8209(21)00053.
    PubMed     Abstract available


    February 2021
  230. KOZAK MM, von Eyben R, Gutkin PM, Vemuri M, et al
    Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Clin Breast Cancer. 2021 Feb 26. pii: S1526-8209(21)00050.
    PubMed     Abstract available


  231. SALVATORE S, Nappi RE, Casiraghi A, Ruffolo AF, et al
    Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up.
    Clin Breast Cancer. 2021 Feb 23. pii: S1526-8209(21)00007.
    PubMed     Abstract available


  232. GURU SD, Hoskin TL, Whaley DH, Nathan MA, et al
    Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections.
    Clin Breast Cancer. 2021 Feb 18. pii: S1526-8209(21)00046.
    PubMed     Abstract available


  233. LEE SJ, Lee J, Jung JH, Park HY, et al
    Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00044.
    PubMed     Abstract available


  234. MA S, Guo C, Sun C, Han T, et al
    Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00047.
    PubMed     Abstract available


  235. BOUZIDI L, Triki H, Charfi S, Kridis WB, et al
    Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
    Clin Breast Cancer. 2021 Feb 16. pii: S1526-8209(21)00045.
    PubMed     Abstract available


  236. JACKISCH C, Barcenas CH, Bartsch R, Palma JD, et al
    Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Feb 6. pii: S1526-8209(21)00043.
    PubMed     Abstract available


  237. HUANG X, Lin S, Rao X, Zeng D, et al
    First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2021 Feb 4. pii: S1526-8209(21)00041.
    PubMed     Abstract available


  238. TESFAW A, Getachew S, Addissie A, Jemal A, et al
    Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study.
    Clin Breast Cancer. 2021;21:e112-e119.
    PubMed     Abstract available


  239. SEFIDBAKHT S, Askarian M, Bijan B, Eghtedari M, et al
    Resuming Breast Imaging Services in the Aftermath of the COVID-19 Pandemic: Safety and Beyond.
    Clin Breast Cancer. 2021;21:e136-e140.
    PubMed     Abstract available


  240. TAKASHIMA T, Hara F, Iwamoto T, Uemura Y, et al
    A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00040.
    PubMed     Abstract available


  241. CAZZANIGA ME, Giordano M, Bandera M, Cassani C, et al
    Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00022.
    PubMed     Abstract available


  242. ERNST A, Flynn KE, Weil EM, Crotty BH, et al
    Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
    Clin Breast Cancer. 2021;21:e38-e47.
    PubMed     Abstract available


  243. INUZUKA M, Watanabe C, Yokoyama S, Kuwayama T, et al
    A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
    Clin Breast Cancer. 2021;21:e48-e52.
    PubMed     Abstract available


  244. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
    Werner Syndrome Protein Expression in Breast Cancer.
    Clin Breast Cancer. 2021;21:57-73.
    PubMed     Abstract available


  245. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
    Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
    Clin Breast Cancer. 2021;21:e22-e37.
    PubMed     Abstract available


  246. MATHIAS BJ, Sun J, Sun W, Zhou JM, et al
    Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Clin Breast Cancer. 2021;21:74-79.
    PubMed     Abstract available


  247. PATEL BK, Samreen N, Zhou Y, Chen J, et al
    MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions.
    Clin Breast Cancer. 2021;21:e102-e111.
    PubMed     Abstract available


  248. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2021;21:e63-e73.
    PubMed     Abstract available


  249. EARLY AP, Moon W
    Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
    Clin Breast Cancer. 2021;21:e96-e101.
    PubMed     Abstract available


  250. GADDAM S, Heller SL, Babb JS, Gao Y, et al
    Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
    Clin Breast Cancer. 2021;21:e74-e79.
    PubMed     Abstract available


  251. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2021;21:10-25.
    PubMed     Abstract available


  252. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2021;21:e88-e95.
    PubMed     Abstract available


  253. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021;21:1-9.
    PubMed     Abstract available


  254. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2021;21:e80-e87.
    PubMed     Abstract available


  255. SAYAN M, Vergalasova I, Jhawar S, Kumar S, et al
    Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Clin Breast Cancer. 2021;21:31-36.
    PubMed     Abstract available


  256. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2021;21:e120-e127.
    PubMed     Abstract available


  257. WAN C, Williams CP, Nipp RD, Pisu M, et al
    Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Clin Breast Cancer. 2021;21:37-46.
    PubMed     Abstract available


  258. TSAI ML, Knaack M, Martone P, Krueger J, et al
    Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
    Clin Breast Cancer. 2021;21:47-56.
    PubMed     Abstract available


  259. VILLASCO A, Agnelli F, D'Alonzo M, Accomasso F, et al
    Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
    Clin Breast Cancer. 2021;21:e53-e62.
    PubMed     Abstract available


    January 2021
  260. DAILY K, Douglas E, Romitti PA, Thomas A, et al
    Epidemiology of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Jan 31. pii: S1526-8209(21)00029.
    PubMed     Abstract available


  261. AGGARWAL A, Adepoju B, Yacur M, Maron D, et al
    Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
    Clin Breast Cancer. 2021 Jan 26. pii: S1526-8209(21)00026.
    PubMed     Abstract available


  262. WU J, Zhou Z
    MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00025.
    PubMed     Abstract available


  263. ANOOP TM, Joseph P R, Pn M, Kp P, et al
    Cutaneous Toxicities in Breast Cancer Patients Receiving Chemotherapy and Targeted Agents--An Observational Clinical Study.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00021.
    PubMed     Abstract available


  264. LIN J, Guo Z, Wang S, Zheng X, et al
    Omission of Chemotherapy in HR+/HER2- Early Invasive Breast Cancer Based on Combined 6-IHC Score?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00023.
    PubMed     Abstract available


  265. SHARMA RD, Sharmin A, Sinha A, Solomon A, et al
    Is it Possible to Predict Non Sentinel Node Positivity on the Basis of mRNA Copy Numbers of CK19 Receptor in Breast Cancer?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00024.
    PubMed     Abstract available


  266. WEI G, Kumar A, Lee MC, Wang X, et al
    Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.
    Clin Breast Cancer. 2021 Jan 19. pii: S1526-8209(21)00020.
    PubMed     Abstract available


  267. LAILLER G, Memoli V, Le Bihan Benjamin C, Ben Diane MK, et al
    Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
    Clin Breast Cancer. 2021 Jan 13. pii: S1526-8209(21)00019.
    PubMed     Abstract available


  268. MARTIN HUERTAS R, Fernandez Abad M, Corral de la Fuente E, Serrano Domingo JJ, et al
    Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00005.
    PubMed     Abstract available


  269. PADMALATHA S, Tsai YT, Ku HC, Wu YL, et al
    Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00004.
    PubMed     Abstract available


  270. KIM HK, Lee HS, Heo MH, Kim JY, et al
    Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00001.
    PubMed     Abstract available


  271. CHEN P, Chen R, Guo H, Cheng J, et al
    CASC15 Polymorphisms are Correlated With Breast Cancer Susceptibility in Chinese Han Women.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00006.
    PubMed     Abstract available


  272. VIDAL GA, Carter GC, Gilligan AM, Saverno K, et al
    Development of a Prognostic Factor Index Among Women With HR(+)/HER2(-) Metastatic Breast Cancer in a Community Oncology Setting.
    Clin Breast Cancer. 2021 Jan 1. pii: S1526-8209(20)30340.
    PubMed     Abstract available


    December 2020
  273. BRYCE Y, Bourguillon R, Vazquez JC, Ziv E, et al
    Prevalence, Outcome, and Management of Risk Factors in Patients With Breast Cancer With Peripheral Arterial Disease: A Tertiary Cancer Center's Experience.
    Clin Breast Cancer. 2020 Dec 30. pii: S1526-8209(20)30338.
    PubMed     Abstract available


  274. MAHTANI R, Kittaneh M, Kalinsky K, Mamounas E, et al
    Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2020 Dec 29. pii: S1526-8209(20)30339.
    PubMed     Abstract available


  275. ZHAO RP, Li Z, Li C, Xu K, et al
    A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women.
    Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30337.
    PubMed     Abstract available


  276. XU N, Zhou J, He X, Ye S, et al
    Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI.
    Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30336.
    PubMed     Abstract available


  277. FERNANDES LE, Epstein CG, Bobe AM, Bell JSK, et al
    Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
    Clin Breast Cancer. 2020 Dec 18. pii: S1526-8209(20)30296.
    PubMed     Abstract available


  278. SAGONA A, Gentile D, Anghelone CAP, Barbieri E, et al
    Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30334.
    PubMed     Abstract available


  279. HUANG X, Mai J, Huang Y, He L, et al
    Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30332.
    PubMed     Abstract available


  280. BALASUBRAMANIAN I, Harding T, Boland MR, Ryan EJ, et al
    The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30333.
    PubMed     Abstract available


  281. CHEN X, Wang J, Fan Y, Luo Y, et al
    Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
    Clin Breast Cancer. 2020 Dec 16. pii: S1526-8209(20)30218.
    PubMed     Abstract available


  282. SATO J, Azuma K, Kinowaki K, Ikeda K, et al
    Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2020 Dec 9. pii: S1526-8209(20)30328.
    PubMed     Abstract available


  283. AL-SALEH K, Aldiab A, Salah T, Arafah M, et al
    Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer.
    Clin Breast Cancer. 2020 Dec 3. pii: S1526-8209(20)30324.
    PubMed     Abstract available


  284. CALI DAYLAN AE, Leone JP
    Targeted Therapies for Breast Cancer Brain Metastases.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30323.
    PubMed     Abstract available


  285. AMMAD UD DIN M, Jamshed S, Patel M
    Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30325.
    PubMed    


    November 2020
  286. SHATNAWI A, Ayoub NM, Alkhalifa AE
    ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30295.
    PubMed     Abstract available


  287. SANNA G, Pestrin M, Moretti E, Biagioni C, et al
    A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30294.
    PubMed     Abstract available


  288. MANLEY H, Mutasa S, Chang P, Desperito E, et al
    Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30291.
    PubMed     Abstract available


  289. MURATA T, Watase C, Shiino S, Jimbo K, et al
    Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30292.
    PubMed     Abstract available


  290. GILBERT A, Williams C, Azuero A, Burkard ME, et al
    Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30293.
    PubMed     Abstract available


  291. HAN Y, Wang J, Sun Y, Yu P, et al
    Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30290.
    PubMed     Abstract available


  292. FAHIM HH, Mohamed G, Safwat G, Abo-Bakr A, et al
    HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30289.
    PubMed     Abstract available


  293. KOZAR N, Kruusmaa K, Bitenc M, Argamasilla R, et al
    Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.
    Clin Breast Cancer. 2020 Nov 11. pii: S1526-8209(20)30232.
    PubMed     Abstract available


  294. KOPETTI C, Schaffer C, Zaman K, Liapi A, et al
    Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review.
    Clin Breast Cancer. 2020 Nov 10. pii: S1526-8209(20)30264.
    PubMed    


  295. LA VERDE N, Collova E, Blasi L, Pinotti G, et al
    Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
    Clin Breast Cancer. 2020 Nov 9. pii: S1526-8209(20)30272.
    PubMed     Abstract available


  296. FORTUNATO L, d'Amati G, Taffurelli M, Tinterri C, et al
    Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey.
    Clin Breast Cancer. 2020 Nov 2. pii: S1526-8209(20)30271.
    PubMed    


    October 2020
  297. KORUCU TS, Ucurum SG, Tastaban E, Ozgun H, et al
    Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery.
    Clin Breast Cancer. 2020 Oct 29. pii: S1526-8209(20)30267.
    PubMed     Abstract available


  298. BRENES SANCHEZ JM, Picado AL, Olivares Crespo ME, Garcia Saenz JA, et al
    Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
    Clin Breast Cancer. 2020 Oct 24. pii: S1526-8209(20)30265.
    PubMed     Abstract available


  299. TAKALA L, Kuusinen TE, Skytta T, Kellokumpu-Lehtinen PL, et al
    Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
    Clin Breast Cancer. 2020 Oct 20. pii: S1526-8209(20)30263.
    PubMed     Abstract available


  300. STRIGEL RM, Bravo E, Tevaarwerk AJ, Anderson BM, et al
    Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.
    Clin Breast Cancer. 2020 Oct 17. pii: S1526-8209(20)30021.
    PubMed     Abstract available


  301. YANG W, He X, He C, Peng L, et al
    Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
    Clin Breast Cancer. 2020 Oct 16. pii: S1526-8209(20)30262.
    PubMed     Abstract available


  302. BOSE S, Kalinsky K
    Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Oct 14. pii: S1526-8209(20)30261.
    PubMed    


  303. CHAN A, Moy B, Mansi J, Ejlertsen B, et al
    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
    Clin Breast Cancer. 2020 Oct 6. pii: S1526-8209(20)30258.
    PubMed     Abstract available


  304. LOH ZJ, Wu TY, Cheng FT
    Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2020 Oct 3. pii: S1526-8209(20)30257.
    PubMed     Abstract available


  305. SAMUEL EZIOKWU A, Varella L, Lynn Kruse M, Jia X, et al
    Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Oct 2. pii: S1526-8209(20)30254.
    PubMed     Abstract available


    September 2020
  306. HAMILTON E, Cortes J, Ozyilkan O, Chen SC, et al
    nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Sep 30. pii: S1526-8209(20)30255.
    PubMed     Abstract available


  307. GOEL AK, Zamre V, Sharma G, Singh D, et al
    Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance.
    Clin Breast Cancer. 2020 Sep 28. pii: S1526-8209(20)30182.
    PubMed    


  308. AGHAMOHAMMADI V, Salari-Moghaddam A, Benisi-Kohansal S, Taghavi M, et al
    Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2020 Sep 24. pii: S1526-8209(20)30253.
    PubMed     Abstract available


  309. HAYASHI N, Yagata H, Tsugawa K, Kajiura Y, et al
    Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER(+) HER2(-) Breast Cancer: A Prospective Phase II Study.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30233.
    PubMed     Abstract available


  310. DUAN X, Liu X, Cao Y, Li Y, et al
    Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(19)30720.
    PubMed     Abstract available


  311. MORANTE Z, Ruiz R, Araujo JM, Pinto JA, et al
    Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30235.
    PubMed     Abstract available


  312. DE SANCTIS V, Alfo M, Vitiello C, Vullo G, et al
    Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
    Clin Breast Cancer. 2020 Sep 10. pii: S1526-8209(20)30220.
    PubMed     Abstract available


  313. FRANCESCHINI D, Loi M, Chiola I, Arculeo S, et al
    Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
    Clin Breast Cancer. 2020 Sep 9. pii: S1526-8209(20)30219.
    PubMed     Abstract available


  314. COCO S, Boccardo S, Mora M, Fontana V, et al
    Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
    Clin Breast Cancer. 2020 Sep 6. pii: S1526-8209(20)30216.
    PubMed     Abstract available


  315. CIURO J, Beyer A, Fritzler J, Jackson N, et al
    Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans.
    Clin Breast Cancer. 2020 Sep 3. pii: S1526-8209(20)30215.
    PubMed     Abstract available


    August 2020
  316. SHAH OS, Soran A, Sahin M, Knapick BA, et al
    Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
    Clin Breast Cancer. 2020 Aug 20. pii: S1526-8209(20)30213.
    PubMed     Abstract available


    July 2020
  317. JAMES J, Teo M, Ramachandran V, Law M, et al
    Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review.
    Clin Breast Cancer. 2020 Jul 8. pii: S1526-8209(20)30170.
    PubMed     Abstract available


    April 2020
  318. GUILLAUME Z, Medioni J, Lillo-Lelouet A, Marret G, et al
    Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.
    Clin Breast Cancer. 2020;20:e192-e195.
    PubMed    


  319. FOUNTZILAS E, Konstantopoulou I, Vagena A, Apostolou P, et al
    Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
    Clin Breast Cancer. 2020;20:152-159.
    PubMed     Abstract available


  320. TU CW, Fang CL, Tsai CB, Hsu CH, et al
    Breast Reconstruction After Resection of Bilateral Giant Phyllodes Tumors: Two Separate Deep Inferior Epigastric Perforator Flaps From One Donor Site.
    Clin Breast Cancer. 2020;20:e188-e191.
    PubMed    


  321. CUTULI B, Lemanski C, De Lafontan B, Chauvet MP, et al
    Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
    Clin Breast Cancer. 2020;20:e164-e172.
    PubMed     Abstract available


  322. CASASANTA N, Kipnis ST, Linville L, Lipinski S, et al
    Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2020;20:125-130.
    PubMed     Abstract available


    February 2020
  323. BURKE EE, Laronga C, Sun W, DeBiase S, et al
    Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
    Clin Breast Cancer. 2020;20:e14-e19.
    PubMed     Abstract available


  324. AYDOGAN T, Sezgin E, Ilvan S, Yilmaz OC, et al
    Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
    Clin Breast Cancer. 2020;20:e9-e13.
    PubMed     Abstract available


  325. SHUI R, Liang X, Li X, Liu Y, et al
    Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.
    Clin Breast Cancer. 2020;20:e65-e74.
    PubMed     Abstract available


  326. ROBERTSON SJ, Pond GR, Hilton J, Petkiewicz SL, et al
    Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information.
    Clin Breast Cancer. 2020;20:61-67.
    PubMed     Abstract available


  327. FUSHIMI A, Kudo R, Takeyama H
    Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?
    Clin Breast Cancer. 2020;20:e82-e88.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: